Letter | Published:

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)

Abstract

SEVERE combined immune deficiency (SCID) represents a hetero-genous group of hereditary diseases. Mutations in the common γ-chain (γc), which is part of several cytokine receptors including those for interleukin (IL)-2, IL-4, IL-7, IL-9 and FL-15, are responsible for X-linked SCID1,2, which is usually associated with a lack of circulating T cells and the presence of B lymphocytes (T- B+ SCID). The gene(s) responsible for autosomal recessive T- B+ SCID is still unknown. The Jak-3 protein kinase3,4 has been found to associate with the γc-chain-containing cytokine receptors4–9. Therefore Jak-3 or other STAT proteins with which it interacts10,11 are candidate genes for autosomal recessive T- B+SCID7. Here we investigate two unrelated T- B+SCID patients (both from consanguineous parents) who have homozygous mutations in the gene for Jak-3. One patient carries a mutation (TyrlOO→Cys) in a conserved tyrosine residue in the JH7 domain of Jak-3 which is absent in more than 150 investigated chromosomes. The other patient carries a homozygous 151-base-pair deletion in the kinase-like domain, leading to a frameshift and premature termination. Both mutations resulted in markedly reduced levels of Jak-3. These findings show that abnormalities in the Jak/STAT signalling pathway can account for SCID in humans.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Noguchi, M. et al. Cell 73, 147–157 (1993).

  2. 2

    Schmaistieg, F. C. et al. J. clin. Invest. 95, 1169–1173 (1995).

  3. 3

    Kawamura, M. et al. Proc. natn. Acad. Sci. U.S.A. 91, 6374–6378 (1994).

  4. 4

    Witthuhn, B. A. et al. Nature 370, 153–157 (1994).

  5. 5

    Johnston, J. A. et al. Nature 370, 151–153 (1994).

  6. 6

    Boussiotis, V. A. et el. Science 266, 1039–1042 (1994).

  7. 7

    Russell, S. M. Science 266, 1042–1045 (1994).

  8. 8

    Myazaki, T. et al. Science 266, 1045–1047 (1994).

  9. 9

    Musso, T. et al. J. exp. Med. 181, 1425–1431 (1995).

  10. 10

    Darnell, J. E., Kerr, I. M. & Start, G. R. Science 264, 1415–1421 (1994).

  11. 11

    Ihle, J. N. & Kerr, I. M. Trends Genet. 11, 69–74 (1995).

  12. 12

    Cao, X. et al. Immunity 2, 223–238 (1995).

  13. 13

    Di Santo, J. P., Muller, W., Guy-Grand, D., Fischer, A. & Rajewsky, K. Proc. natn. Acad. Sci. U.S.A. 93, 377–381 (1995).

  14. 14

    Gougeon, M.-L. et al. J. Immun. 145, 2873–2877 (1990).

  15. 15

    Wengler, G. S., Allen, R. C., Parolini, O., Smith, H. & Conley, M. E. J. Immun. 150, 700–704 (1993).

  16. 16

    Puck, J. M., Nussbaum, R. L. & Conley M. E. J. clin. Invest. 79, 1395–1400 (1987).

  17. 17

    Conley, M. E. et al. Proc. natn. Acad. Sci. U.S.A. 85, 3090–3094 (1988).

  18. 18

    Chomczynski, P. & Sacchi, N. Analyt. Biochem. 162, 156–159 (1987).

  19. 19

    Villa, A. et al. Nature Genet. 9, 414–417 (1995).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.